AU2095599A - Human genes and gene expression products i - Google Patents
Human genes and gene expression products iInfo
- Publication number
- AU2095599A AU2095599A AU20955/99A AU2095599A AU2095599A AU 2095599 A AU2095599 A AU 2095599A AU 20955/99 A AU20955/99 A AU 20955/99A AU 2095599 A AU2095599 A AU 2095599A AU 2095599 A AU2095599 A AU 2095599A
- Authority
- AU
- Australia
- Prior art keywords
- gene expression
- expression products
- human genes
- genes
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6875597P | 1997-12-23 | 1997-12-23 | |
US60068755 | 1997-12-23 | ||
US8066498P | 1998-04-03 | 1998-04-03 | |
US60080664 | 1998-04-03 | ||
US10523498P | 1998-10-21 | 1998-10-21 | |
US60105234 | 1998-10-21 | ||
US10587798P | 1998-10-27 | 1998-10-27 | |
US60105877 | 1998-10-27 | ||
US21747198A | 1998-12-21 | 1998-12-21 | |
US09217471 | 1998-12-21 | ||
PCT/US1998/027610 WO1999033982A2 (en) | 1997-12-23 | 1998-12-22 | Human genes and gene expression products i |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2095599A true AU2095599A (en) | 1999-07-19 |
Family
ID=27535805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU20955/99A Abandoned AU2095599A (en) | 1997-12-23 | 1998-12-25 | Human genes and gene expression products i |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1190058A2 (de) |
JP (1) | JP2002500010A (de) |
AU (1) | AU2095599A (de) |
WO (1) | WO1999033982A2 (de) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6617438B1 (en) * | 1997-11-05 | 2003-09-09 | Sirna Therapeutics, Inc. | Oligoribonucleotides with enzymatic activity |
US8101349B2 (en) | 1997-12-23 | 2012-01-24 | Novartis Vaccines And Diagnostics, Inc. | Gene products differentially expressed in cancerous cells and their methods of use II |
US6448005B1 (en) * | 1998-06-30 | 2002-09-10 | Millennium Pharmaceuticals, Inc. | 14723 Receptor, a novel G-protein coupled receptor |
US7534579B2 (en) | 1998-06-30 | 2009-05-19 | Millennium Pharmaceuticals, Inc. | 14273 receptor, a novel G-protein coupled receptor |
AU4728599A (en) | 1998-06-30 | 2000-01-17 | Millennium Pharmaceuticals, Inc. | 14273 receptor, a g-protein coupled receptor |
US6395877B1 (en) | 1998-06-30 | 2002-05-28 | Millennium Pharmaceuticals, Inc. | 14273 receptor, a novel G-protein coupled receptor |
JP2003530816A (ja) * | 1998-09-28 | 2003-10-21 | カイロン コーポレイション | ヒト遺伝子および遺伝子発現産物 |
JP2003521231A (ja) * | 1999-01-29 | 2003-07-15 | インサイト・ファーマスーティカルズ・インコーポレイテッド | 核酸結合タンパク質 |
EP2301947A3 (de) * | 1999-02-26 | 2011-11-23 | Millennium Pharmaceuticals, Inc. | Sekretierte Proteine und Verwendungen dafür |
US7083793B2 (en) | 1999-02-26 | 2006-08-01 | Millennium Pharmaceuticals, Inc. | Tango 243 polypeptides and uses thereof |
US6647341B1 (en) * | 1999-04-09 | 2003-11-11 | Whitehead Institute For Biomedical Research | Methods for classifying samples and ascertaining previously unknown classes |
WO2000065067A2 (en) * | 1999-04-23 | 2000-11-02 | University Of Washington | Prostate-specific polynucleotides, polypeptides and their methods of use |
WO2001009318A1 (fr) * | 1999-07-29 | 2001-02-08 | Helix Research Institute | Genes associes au cancer du foie |
JP2003506042A (ja) | 1999-08-03 | 2003-02-18 | ミレニアム ファーマシューティカルズ インク. | セクレチン様ファミリーの新規gpcr様分子15571及びその使用 |
CN1300845A (zh) * | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | 一种新的多肽-人二酰基甘油蛋白激酶亚单位9和编码这种多肽的多核苷酸 |
AU2153401A (en) * | 1999-12-29 | 2001-07-16 | Aros Applied Biotechnology Aps | Gene expression in biological conditions |
DE10004102A1 (de) * | 2000-01-31 | 2002-06-20 | Metagen Pharmaceuticals Gmbh | Nachweis von differenzieller Genexpression |
AU2001238144A1 (en) * | 2000-02-09 | 2001-08-20 | Agensys, Inc. | 83p5g4: a tissue specific protein highly expressed in prostate cancer |
US6627423B2 (en) | 2000-03-24 | 2003-09-30 | Millennium Pharmaceuticals, Inc. | 21481, a novel dehydrogenase molecule and uses therefor |
US6511834B1 (en) | 2000-03-24 | 2003-01-28 | Millennium Pharmaceuticals, Inc. | 32142,21481,25964,21686, novel human dehydrogenase molecules and uses therefor |
WO2001072781A2 (en) * | 2000-03-28 | 2001-10-04 | Chiron Corporation | Human genes and expression products |
EP1326985A1 (de) * | 2000-08-18 | 2003-07-16 | MERCK PATENT GmbH | Identifizierung eines menschlichen n-terminalen acetyltransferase-gens |
WO2002077232A2 (en) | 2000-11-22 | 2002-10-03 | Diadexus, Inc. | Compositions and methods relating to breast specific genes and proteins |
US7601825B2 (en) | 2001-03-05 | 2009-10-13 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer |
US6924358B2 (en) | 2001-03-05 | 2005-08-02 | Agensys, Inc. | 121P1F1: a tissue specific protein highly expressed in various cancers |
US7927597B2 (en) | 2001-04-10 | 2011-04-19 | Agensys, Inc. | Methods to inhibit cell growth |
CA2443123A1 (en) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
DE10118452A1 (de) * | 2001-04-12 | 2002-10-31 | Joern Bullerdiek | Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse |
US7125699B2 (en) * | 2001-08-16 | 2006-10-24 | Merck Patent Gmbh | Identification of a human N-terminal acetyltransferase gene |
AU2003211696A1 (en) * | 2002-03-07 | 2003-09-16 | Bf Research Institute, Inc. | p18ABetarP GENE AND p18ABetarP PROTEIN, NOVEL GENE/PROTEIN (p60TRP) INTERACTING THEREWITH TO INHIBIT CELL DEATH AND CELL DEATH PROMOTER |
EP1426442A1 (de) * | 2002-12-02 | 2004-06-09 | MTM Laboratories AG | Markermoleküle, die mit colorektalen Läsionen assoziiert sind |
US7306910B2 (en) * | 2003-04-24 | 2007-12-11 | Veridex, Llc | Breast cancer prognostics |
EP3611266B1 (de) | 2005-08-23 | 2022-11-09 | The Trustees of the University of Pennsylvania | Modifizierte nukleoside enthaltende rna und verfahren zur verwendung davon |
EP2600901B1 (de) | 2010-08-06 | 2019-03-27 | ModernaTX, Inc. | Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung |
CN104531671A (zh) | 2010-10-01 | 2015-04-22 | 现代治疗公司 | 设计核酸及其使用方法 |
CA2831613A1 (en) | 2011-03-31 | 2012-10-04 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
EP3682905B1 (de) | 2011-10-03 | 2021-12-01 | ModernaTX, Inc. | Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon |
ES2923757T3 (es) | 2011-12-16 | 2022-09-30 | Modernatx Inc | Composiciones de ARNm modificado |
US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
US9303079B2 (en) | 2012-04-02 | 2016-04-05 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
AU2013243953A1 (en) | 2012-04-02 | 2014-10-30 | Modernatx, Inc. | Modified polynucleotides for the production of nuclear proteins |
DK2922554T3 (en) | 2012-11-26 | 2022-05-23 | Modernatx Inc | Terminalt modificeret rna |
WO2014160243A1 (en) | 2013-03-14 | 2014-10-02 | The Trustees Of The University Of Pennsylvania | Purification and purity assessment of rna molecules synthesized with modified nucleosides |
US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
WO2015048744A2 (en) | 2013-09-30 | 2015-04-02 | Moderna Therapeutics, Inc. | Polynucleotides encoding immune modulating polypeptides |
WO2015051214A1 (en) | 2013-10-03 | 2015-04-09 | Moderna Therapeutics, Inc. | Polynucleotides encoding low density lipoprotein receptor |
US11364292B2 (en) | 2015-07-21 | 2022-06-21 | Modernatx, Inc. | CHIKV RNA vaccines |
US11007260B2 (en) | 2015-07-21 | 2021-05-18 | Modernatx, Inc. | Infectious disease vaccines |
MD3718565T2 (ro) | 2015-10-22 | 2022-09-30 | Modernatx Inc | Vaccinuri împotriva virusului respirator |
WO2017070613A1 (en) | 2015-10-22 | 2017-04-27 | Modernatx, Inc. | Human cytomegalovirus vaccine |
EP3364950A4 (de) | 2015-10-22 | 2019-10-23 | ModernaTX, Inc. | Impfstoffe gegen tropenkrankheiten |
US20200255901A1 (en) * | 2016-08-04 | 2020-08-13 | Shizuoka Prefecture | Method for determining presence or absence of risk of developing cancer |
JP6980780B2 (ja) | 2016-10-21 | 2021-12-15 | モデルナティーエックス, インコーポレイテッド | ヒトサイトメガロウイルスワクチン |
US11103578B2 (en) | 2016-12-08 | 2021-08-31 | Modernatx, Inc. | Respiratory virus nucleic acid vaccines |
EP3582790A4 (de) | 2017-02-16 | 2020-11-25 | ModernaTX, Inc. | Hochwirksame immunogene zusammensetzungen |
US10653767B2 (en) | 2017-09-14 | 2020-05-19 | Modernatx, Inc. | Zika virus MRNA vaccines |
US11351242B1 (en) | 2019-02-12 | 2022-06-07 | Modernatx, Inc. | HMPV/hPIV3 mRNA vaccine composition |
US11406703B2 (en) | 2020-08-25 | 2022-08-09 | Modernatx, Inc. | Human cytomegalovirus vaccine |
CN112233741B (zh) * | 2020-09-30 | 2024-03-01 | 吾征智能技术(北京)有限公司 | 一种基于聚类的文本分类系统、设备、存储介质 |
-
1998
- 1998-12-22 JP JP2000526638A patent/JP2002500010A/ja not_active Withdrawn
- 1998-12-22 WO PCT/US1998/027610 patent/WO1999033982A2/en not_active Application Discontinuation
- 1998-12-25 EP EP98965500A patent/EP1190058A2/de not_active Withdrawn
- 1998-12-25 AU AU20955/99A patent/AU2095599A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999033982A3 (en) | 1999-12-23 |
WO1999033982A2 (en) | 1999-07-08 |
EP1190058A2 (de) | 2002-03-27 |
JP2002500010A (ja) | 2002-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2095599A (en) | Human genes and gene expression products i | |
AU4187499A (en) | Human genes and gene expression products v | |
AU4053699A (en) | Novel human genes and gene expression products | |
AU6069300A (en) | Novel human genes and gene expression products | |
AU2001285047A1 (en) | Human genes and gene expression products | |
AU2001245619A1 (en) | Human genes and gene expression products | |
AU5730896A (en) | Fucosyltransferase genes and uses thereof | |
AUPP249298A0 (en) | Synthetic genes and genetic constructs comprising same I | |
AU2001249125A1 (en) | Human fgf-23 gene and gene expression products | |
AU6418498A (en) | Human genes | |
AU2809897A (en) | Novel human cytomegalovirus dna constructs and uses therefor | |
AU2001245535A1 (en) | Human fgf-23 gene and gene expression products | |
AU4803997A (en) | Polymorphisms and new genes in the region of the human hemochromatosis gene | |
AU8536998A (en) | Regulatory sequences involved in hypoxia regulated gene expression and uses thereof | |
AU8490998A (en) | Glutenin genes and their uses | |
IL136826A0 (en) | Essential bacterial genes and their use | |
AU1101901A (en) | Human fgf-20 gene and gene expression products | |
GB9708526D0 (en) | Eukaryotic gene expression cassette and uses thereof | |
AU4329300A (en) | Human mesenchymal dnas and expression products | |
AU6263999A (en) | Human genes and gene expression products | |
AU4862396A (en) | Human obesity gene | |
AU3717797A (en) | Method to co-detect introduced genes and their products | |
AU9131698A (en) | Human genes regulated by human cytomegalovirus and interferon | |
AU3133799A (en) | Seed-coat promoters, genes and gene products | |
AU2001287269A1 (en) | Human genes and expression products |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |